SEC Form 4 · accession 0001493152-26-036438
CLEARONE INC · CLRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Aug 4, 2026
Accepted (ET)
Aug 6, 2026 · 7:44 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000840715
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Purchase WarrantF1 | $5.00 | Aug 4, 2026 | J | 437,500 | D | — | — | Common Stock | 437,500 | 0 | D |
Explanation of responses
- F1On August 4, 2026, pursuant to the Agreement and Plan of Merger by and among ClearOne, Inc. (the "Issuer"), CLRO Merger Sub, Inc., a wholly-owned subsidiary of the Issuer ("Merger Sub"), Cortigent, Inc. ("Cortigent"), and Vivani Medical, Inc., pursuant to which Merger Sub will merge with and into Cortigent, with Cortigent surviving as a wholly-owned subsidiary of the Issuer, First Finance Ltd. entered into a Warrant Cancellation Agreement with the Issuer pursuant to which First Finance Ltd. surrendered and cancelled the Common Stock Purchase Warrant in its entirety for no consideration. As a result of the Warrant Cancellation Agreement, First Finance Ltd. no longer holds any derivative securities of the Issuer. The Common Stock Purchase Warrant was exercisable six months from the original closing date (March 6, 2026) and was set to expire two years from the closing date.